Abstract
This study was performed to determine whether phenotypically healthy sisters of women with polycystic ovary syndrome (PCOS) have evidence of insulin resistance. We studied 54 women: 17 with PCOS, 17 sisters of these probands and 20 control women with similar age, body mass index (BMI) and waist-to-hip ratio (WHR). The PCOS sisters had neither clinical nor laboratory evidence of hyperandrogenism. However, estimated insulin resistance indices indicated decreased insulin sensitivity in PCOS sisters compared with the controls. No difference of insulin resistance indices was detected between the PCOS and their sisters. This finding provides additional evidence that there is a hereditary trait regarding insulin resistance in the PCOS families.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83: 3078–82.
Diamanti-Kandarakis E, Kouli C, Bergiele A, et al. A survey of the PCOS in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84: 4006–11.
Dunaif A, Givens JR, Haseltine FP, Merriam GR. Polycystic ovary syndrome. Current issues in endocrinology and metabolism. Boston: Blackwell, 1992.
Diamanti-Kandarakis E, Dunaif A. New perspectives in PCOS. Trends Endocrinol Metab 1996, 7: 267–71.
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999, 22: 141–6.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999, 84: 165–9.
Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in Polycystic Ovarian Syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 2004, 150: 795–800.
Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G, Tengborn L. Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 1994, 61: 455–60.
Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995, 96: 520–7.
Dunaif A, Finegood DT. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996, 81: 942–7.
Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss III JF, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 1998, 53: 217–56.
Franks S, Gharani N, Waterworth D, et al. Genetics of polycystic ovary syndrome. Mol Cell Endocrinol 1998, 145: 123–8.
Legro RS. Polycystic ovary syndrome. Phenotype to genotype. Endocrinol Metab Clin North Am 1999, 28: 379–96.
Cooper H, Spellacy W, Prem K, Cohen W. Hereditary factors in the Stein-Levanthal syndrome. Am J Obstet Gynecol 1968, 100: 371–87.
Givens JR. Familial polycystic ovarian disease. Endocrinol Metab Clin North Am 1988, 17: 771–83.
Lunde O, Magnus P, Sandvik L, Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 1989, 28: 23–30.
Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence of a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 1993, 38: 653–8.
Govind A, Obhrai MS, Clayton RN. Polycystic Ovaries Are Inherited as an Autosomal Dominant Trait: Analysis of 29 Polycystic Ovary Syndrome and 10 Control Families. J Clin Endocrinol Metab 1999, 84: 38–43.
Wilroy Jr RS, Given JR, Wiser WL, Coleman SA, Andersen RN, Summitt RL. Hyperthecosis: an inheritable form of polycystic ovarian disease. Birth Defects Orig Artic Ser 1975, 11: 81–5.
Legro R, Bentlet- Lewis R, Driscoll D, Wang SC, Dunaif A. Insulin resistance in the sisters of women polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 2002, 87: 2128–33.
Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003. 88: 2031–6.
Norman RJ, Masters S, Hague W. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril 1996, 66: 942–7.
Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 2001, 86: 2027–31.
Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001, 75: 53–8.
Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987, 65: 499–507.
Robinson S, Kiddy D, Gelding SV, et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 1993, 39: 351–5.
Walker BR, Rodin A, Taylor NF, Clayton RN. Endogenous inhibitors of 11β-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome. Clin Endocrinol (Oxf) 2000, 52: 77–80.
Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85: 2402–10.
Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987, 79: 790–800.
Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001, 24: 89–94.
Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican- Americans. Diabetes 1995, 44: 1386–91.
American Diabetes Association. Screening for diabetes. Diabetes Care 2002, 25: 21–4.
Legro, RS, Driscoll, D, Strauss III JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998, 95: 14956–60.
Franks S. Polycystic ovary syndrome. N Engl J Med 1995, 333: 853–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Diamanti-Kandarakis, E., Alexandraki, K., Bergiele, A. et al. Presence of metabolic risk factors in non-obese PCOS sisters: Evidence of heritability of insulin resistance. J Endocrinol Invest 27, 931–936 (2004). https://doi.org/10.1007/BF03347535
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347535